Learn more
Every year, 10 million people die unnecessarily because they lack access to existing medical treatments; high prices and legal barriers are often contributing factors. A further billion people are infected with one or more so-called “neglected” diseases, for which safe and effective treatments have not been developed because the sufferers are too poor to provide an economic incentive.
In both cases, universities are well-placed to make a difference. University scientists are major contributors to the drug development pipeline. At the same time, universities are commited to advancing the public good.
Introductory video
 |
From TEDxTerryTalks 2008:
“Making medicines for people, not for profit” |
Introductory readings
- Introduction to Access to Essential Medicines
- Introduction to Neglected Diseases and the Research Gap
- Introduction to International Patent Law
- History of UAEM at UBC
- UILO: Principles for Global Access to UBC Technologies
Glossary
